Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
February 28, 2007

Peptisyntha Expands Production Capacity in Brussels.

  • Peptisyntha SA launched the expansion of its pilot-scale capacity for the production of cGMP bulk peptides based on solution phase technology at its production plant in Brussels. The expansion includes an additional pilot HPLC purification unit, an additional pilot freeze-dryer, and an additional pilot plant for the chemical synthesis of peptides. All the new units are scheduled to be fully operational in 2007.

    The current development follows the recent expansion of the solid phase peptide synthesis capacity implemented by Peptisyntha, Inc. in Torrance, CA, which came on stream in 2006. Peptisyntha SA and Peptisyntha Inc. are fully owned subsidiaries of Solvay.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.